You are a subscriber
If you are not already a subscriber,
Choose a subscription offer and create your account to read all content on MediapartCreate your account
In China and the United States, as well as France, the drug chloroquine is one of the main focal points in the race to provide an effective treatment for the Covid-19 coronavirus. So far there is still insufficient data to show whether this anti-malaria drug will prove useful in treating people infected with the virus. And a French study praising its benefits has become mired in controversy. Rouguyata Sall reports.
Reading articles is for subscribers only. Subscribe now.